Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 05.10.2026 1 Am J Ophthalmol 1 Br J Cancer 2 Br J Dermatol 1 J Am Acad Dermatol 1 J Clin Invest 1 J Invest Dermatol 3 Melanoma Res 1 Nat Med 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. KNAPPE C, Prystupa C, Jami Z, Bonsen LSZ, et al
   Subbasal Nerve Plexus Alterations Following Ocular Proton Therapy in Uveal Melanoma Assessed by Corneal Confocal Microscopy.
   Am J Ophthalmol. 2026 Oct 1:S0002-9394(26)00548.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. POON KS, Koay ES
   CBL in stage II melanoma: considerations of variant interpretation for driver gene designation.
   Br J Cancer. 2026 Oct 1. doi: 10.1038/s41416-026-03629.
   PubMed        
   
   

   
   Br J Dermatol

3. BELL KJL, Adamson AS, Parker L, van Akkooi ACJ, et al
   Goals of melanoma surveillance: focusing on outcomes that matter most.
   Br J Dermatol. 2026 Oct 1:ljag430. doi: 10.1093.
   PubMed        
   
   
4. BALADO-SIMO P, Podlipnik S
   Low-risk lesion, increased-risk patient: separating lesion prognosis from future melanoma risk.
   Br J Dermatol. 2026 Sep 30:ljag427. doi: 10.1093.
   PubMed        
   
   

   
   J Am Acad Dermatol

5. HEYMANN WR
   Parkinson Disease, Melanoma, and the Dermatologist.
   J Am Acad Dermatol. 2026 Sep 28:S0190-9622(26)03640.
   PubMed        
   
   

   
   J Clin Invest

6. YAO T, Chen RE, Yamada M, Moore JR, et al
   Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity.
   J Clin Invest. 2026 Sep 29:e211137. doi: 10.1172/JCI211137.
   PubMed        
   
   

   
   J Invest Dermatol

7. KLEIN K, Johnson L, Rica R, Sarcevic M, et al
   Langerhans cell-targeted mRNA delivery: A strategy for dose-sparing and enhanced antitumor immunity.
   J Invest Dermatol. 2026;146:2793-2801.
   PubMed         Abstract available
   
   

   
   Melanoma Res

8. WANG F, Meng X, Guo R, Zhou X, et al
   Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus.
   Melanoma Res. 2026 Oct 5. doi: 10.1097/CMR.0000000000001142.
   PubMed         Abstract available
   
   
9. DUMAN N, Ozel A, Degirmenci D, Yaman B, et al
   Dissociation between systemic inflammatory markers and the tumor microenvironment in predicting sentinel lymph node metastasis in cutaneous melanoma.
   Melanoma Res. 2026 Sep 29. doi: 10.1097/CMR.0000000000001139.
   PubMed         Abstract available
   
   
10. WANG B, Tran S, Clark M
    Association between perioperative antidepressant use and postoperative outcomes after cutaneous melanoma resection.
    Melanoma Res. 2026 Sep 29. doi: 10.1097/CMR.0000000000001144.
    PubMed         Abstract available
    
    

    
    Nat Med

11. LONG GV, Pires da Silva I, Perry KA, Romano J, et al
    Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
    Nat Med. 2026 Oct 1. doi: 10.1038/s41591-026-04677.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. ZHOU R, Xu T, Shen Z, Zhang Y, et al
    PAK4 exacerbates melanoma immunosuppression by promoting exosome release.
    Proc Natl Acad Sci U S A. 2026;123:e2536086123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum